Development of the Mainz Resilience Assessment for Pediatric Cancer: A New Age-Specific Patient-Reported Outcome Tool to Evaluate Resilience in Young Cancer Patients - Poll - MDSpire

Development of the Mainz Resilience Assessment for Pediatric Cancer: A New Age-Specific Patient-Reported Outcome Tool to Evaluate Resilience in Young Cancer Patients

  • By

  • Marie A. Neu

  • Franziska Ortmüller

  • Abigale L. Robinson

  • Elias Dreismickenbecker

  • Henrike Otto

  • Lena Wypyrsczyk

  • Mareike Kühn

  • Michèle Wessa

  • Oliver Tüscher

  • Joerg Faber

  • February 26, 2026

  • 0 min

Share

Original Source(s)

Development of the Mainz Resilience Assessment for Pediatric Cancer: A New Age-Specific Patient-Reported Outcome Tool to Evaluate Resilience in Young Cancer Patients

  • by Marie A. Neu, Franziska Ortmüller, Abigale L. Robinson, Elias Dreismickenbecker, Henrike Otto, Lena Wypyrsczyk, Mareike Kühn, Michèle Wessa, Oliver Tüscher, Joerg Faber

  • February 26, 2026

Related Content

Emerging applications of artificial intelligence for risk stratification in head and neck cancer: a scoping review

Prospective phase II study of frontline Helicobacter pylori eradication therapy for early-stage extragastric mucosa-associated lymphoid tissue lymphoma

Stimuli-responsive nanoplatforms for sonodynamic immunotherapy: opportunities and challenges in cancer treatment